Last week Heather Howard spoke on a panel about Medicaid buy-in and states as laboratories of health reform. For those of you interested in learning more about Medicaid buy-in, or public option, as some states refer to it, check out SHVS's map that tracks state activity. SHVS updates it regularly to reflect the latest developments and new proposals coming out of your states.
Last week, Covered California, the Massachusetts Health Connector and the Washington Health Benefit Exchange together produced a new report that outlines the benefits of state-based exchanges, particularly in the areas of controlling premium costs and attracting new enrollment. The report examines how state and federal actions affected premiums and new enrollment, and finds that premium increases in these states were less than half of what consumers saw in the 39 states that relied on the federally facilitated marketplace (FFM) between 2014 and 2019.
Last week was a busy one on Capitol Hill as the future of health care was discussed. On Tuesday, the Senate Finance Committee held a hearing on drug pricing with testimony provided by seven pharmaceutical executives. For a roundup of the major takeaways from the hearing, the Washington Post’s Health 202 blog has an analysis. The hearing and a new health care reform proposal introduced in the House on Wednesday are explored in detail in this week’s What the Health podcast episode.